Redefining the Diagnosis and Therapy of COPD: Lessons from COPDGene, GOLD Reports, and Precision Medicine Evaluation (ID: i759a)

Question Title

* 1. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

If not committed or do not plan to make changes, please indicate reason

Question Title

* 2. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

Question Title

* 3. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Greater skill at identifying patients with undiagnosed COPD and assessing their level of disease severity

Improved ability to diagnose and assess exacerbation risk among patients with airway diseases

Comprehensive knowledge of evidence on the utility of smoking cessation, vaccinations, and other prevention strategies for improving outcomes for patients with COPD

Deeper understanding of the need to provide timely pharmacologic therapies to alleviate symptoms and reduce exacerbations in patients with COPD

Improved knowledge of the treatable traits approach and current GOLD recommendations for individualized management of patients with COPD

Question Title

* 4. What barriers do you see to making changes in your practice?

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please specify)

Question Title

* 5. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

After participating in today’s activity, I am now better able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Identify clinical, functional, and radiological characteristics that can facilitate earlier COPD diagnosis and recognition of those who can benefit from available therapies	Identify clinical, functional, and radiological characteristics that can facilitate earlier COPD diagnosis and recognition of those who can benefit from available therapies Strongly agree	Identify clinical, functional, and radiological characteristics that can facilitate earlier COPD diagnosis and recognition of those who can benefit from available therapies Agree	Identify clinical, functional, and radiological characteristics that can facilitate earlier COPD diagnosis and recognition of those who can benefit from available therapies Neutral	Identify clinical, functional, and radiological characteristics that can facilitate earlier COPD diagnosis and recognition of those who can benefit from available therapies Disagree	Identify clinical, functional, and radiological characteristics that can facilitate earlier COPD diagnosis and recognition of those who can benefit from available therapies Strongly disagree
Recognize the importance of smoking cessation, early treatment, and other prevention approaches in alleviating the burden of COPD	Recognize the importance of smoking cessation, early treatment, and other prevention approaches in alleviating the burden of COPD Strongly agree	Recognize the importance of smoking cessation, early treatment, and other prevention approaches in alleviating the burden of COPD Agree	Recognize the importance of smoking cessation, early treatment, and other prevention approaches in alleviating the burden of COPD Neutral	Recognize the importance of smoking cessation, early treatment, and other prevention approaches in alleviating the burden of COPD Disagree	Recognize the importance of smoking cessation, early treatment, and other prevention approaches in alleviating the burden of COPD Strongly disagree
Apply precision medicine–based approaches and current GOLD strategy to improve individualized treatment of COPD	Apply precision medicine–based approaches and current GOLD strategy to improve individualized treatment of COPD Strongly agree	Apply precision medicine–based approaches and current GOLD strategy to improve individualized treatment of COPD Agree	Apply precision medicine–based approaches and current GOLD strategy to improve individualized treatment of COPD Neutral	Apply precision medicine–based approaches and current GOLD strategy to improve individualized treatment of COPD Disagree	Apply precision medicine–based approaches and current GOLD strategy to improve individualized treatment of COPD Strongly disagree
Describe the ongoing evolution of COPD diagnosis and its management in the era of COVID-19	Describe the ongoing evolution of COPD diagnosis and its management in the era of COVID-19 Strongly agree	Describe the ongoing evolution of COPD diagnosis and its management in the era of COVID-19 Agree	Describe the ongoing evolution of COPD diagnosis and its management in the era of COVID-19 Neutral	Describe the ongoing evolution of COPD diagnosis and its management in the era of COVID-19 Disagree	Describe the ongoing evolution of COPD diagnosis and its management in the era of COVID-19 Strongly disagree

Question Title

* 6. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

Gerard Criner, MD, FACP, FACCP, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the Material	Presented the Material Strongly agree	Presented the Material Agree	Presented the Material Neutral	Presented the Material Disagree	Presented the Material Strongly disagree
Avoided Commercial Bias	Avoided Commercial Bias Strongly agree	Avoided Commercial Bias Agree	Avoided Commercial Bias Neutral	Avoided Commercial Bias Disagree	Avoided Commercial Bias Strongly disagree

Question Title

* 7. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

Fernando J. Martinez, MD, MS, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the Material	Presented the Material Strongly agree	Presented the Material Agree	Presented the Material Neutral	Presented the Material Disagree	Presented the Material Strongly disagree
Avoided Commercial Bias	Avoided Commercial Bias Strongly agree	Avoided Commercial Bias Agree	Avoided Commercial Bias Neutral	Avoided Commercial Bias Disagree	Avoided Commercial Bias Strongly disagree

Question Title

* 8. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

Ruth Tal-Singer, PhD, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the Material	Presented the Material Strongly agree	Presented the Material Agree	Presented the Material Neutral	Presented the Material Disagree	Presented the Material Strongly disagree
Avoided Commercial Bias	Avoided Commercial Bias Strongly agree	Avoided Commercial Bias Agree	Avoided Commercial Bias Neutral	Avoided Commercial Bias Disagree	Avoided Commercial Bias Strongly disagree

Question Title

* 9. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 10. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 11. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for this or related disease state:

Question Title

* 1. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 2. Which of the following best describes the impact of this activity on your performance?

Question Title

* 3. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 4. What barriers do you see to making changes in your practice?

Question Title

* 5. Please rate your level of agreement by checking the appropriate rating.5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree After participating in today’s activity, I am now better able to:

Question Title

* 6. Please rate your level of agreement by checking the appropriate rating.5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree Gerard Criner, MD, FACP, FACCP, effectively:

Question Title

* 7. Please rate your level of agreement by checking the appropriate rating.5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree Fernando J. Martinez, MD, MS, effectively:

Question Title

* 8. Please rate your level of agreement by checking the appropriate rating.5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree Ruth Tal-Singer, PhD, effectively:

Question Title

* 9. Please rate your level of agreement by checking the appropriate rating.5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree The content presented:

Question Title

* 10. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 11. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for this or related disease state:

Question Title

* 12. If you indicated that you perceived commercial bias or influence, please describe:

* 5. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

After participating in today’s activity, I am now better able to:

* 6. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

Gerard Criner, MD, FACP, FACCP, effectively:

* 7. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

Fernando J. Martinez, MD, MS, effectively:

* 8. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

Ruth Tal-Singer, PhD, effectively:

* 9. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

The content presented: